Latest Cisplatin Stories
- Data support VAL-083's importance as a potential therapy for non-small cell lung cancer (NSCLC), including drug-resistant NSCLC - VANCOUVER, British Columbia and MENLO PARK, Calif.,
SAN DIEGO, Nov.
SAN DIEGO, Nov.
Doctors in France are calling the naturally occurring vegetable compound PEITC a “potential new therapeutic strategy” for malignant pleural mesothelioma. Raleigh,
DelMar Pharmaceuticals Presents Data at AACR's New Horizons in Cancer Research Conference in Shanghai, China VANCOUVER, British Columbia, MENLO PARK, Calif. and SHANGHAI, Oct.
LifeScienceIndustryResearch.com adds latest Report on “Global and Chinese Cisplatin (CAS 15663-27-1) Industry, 2009-2019 Market Research Report” to its store.
EAST SETAUKET, N.Y., June 18, 2014 /PRNewswire/ -- The journal Molecular Cancer Therapeutics has published an article on Lixte's lead compound LB-100 entitled "Inhibition of protein
Proof-of-Concept Trial Targets DNA Repair in Bile Duct Cancers SAN DIEGO and NEW TAIPEI CITY, Taiwan, June 17, 2014 /PRNewswire-iReach/ -- Senhwa Biosciences, Inc.
-- Difficult-to-treat squamous NSCLC patients saw clinical benefit with necitumumab plus chemotherapy regimen -- INDIANAPOLIS, May 14, 2014 /PRNewswire/ -- Lung cancer patients with
Polaris Group Scientific Colleagues from Several University Cancer Centers Present Data at 2014 AACR Meeting in San Diego, CA SAN DIEGO, April 29, 2014 /PRNewswire/ -- Polaris Group
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.